SCHEMBL13601726

SCHEMBL13601726

CCCCOC(=O)C(=O)N1CCN(C)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
GAA P10253 2/20 0.43
ALDH1A1 P00352 4/20 0.42
NPC1 O15118 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.41
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
HTR1A P08908 1/20 0.41
ATM Q13315 1/20 0.40
HRH2 P25021 1/20 0.40
HRH1 P35367 1/20 0.40
TSHR P16473 4/20 0.40
TDP1 Q9NUW8 2/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 4/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601725 0.93 TSHR (0.49) SMN1; SMN2LMNAPOLBGAAALDH1A1
SCHEMBL13601724 0.89 MAPT (0.44) GAAALDH1A1NPC1KDM4EMAPT
SCHEMBL28060009 0.84 ALDH1A1 (0.53) SMN1; SMN2LMNAPOLBALDH1A1NPC1
SCHEMBL5594524 0.82 POLB (0.65) SMN1; SMN2LMNAPOLBGAAALDH1A1
SCHEMBL13601729 0.82 MAPT (0.39) GAAALDH1A1NPC1MAPTHTR1A
SCHEMBL13601717 0.82 MAPT (0.59) SMN1; SMN2POLBGAAALDH1A1KDM4E
SCHEMBL5875276 0.81 SMN1; SMN2 (0.44) SMN1; SMN2LMNAPOLBGAAALDH1A1
SCHEMBL12881455 0.81 GNAI3 (0.58) SMN1; SMN2GAAMAPTTHRATHRB
SCHEMBL12881468 0.80 GNAI3 (0.42) SMN1; SMN2GAAMAPTTHRATHRB
SCHEMBL12881482 0.80 GNAI3 (0.42) SMN1; SMN2GAAMAPTTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed